ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/27/2026
Back to search
Official data from USPTO
EAGLE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EAGLE PHARMACEUTICALS
ST13
US500000086296582Class
35, 42
Filing
86296582
Registration
4876691
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/28/2026
Trademark type
Word
Nice classes
35, 42
Filing date
05/30/2014
Registration date
12/29/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
04/28/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
09/06/2011
First use in commerce
09/06/2011
Drawing code
4
Owner type
03
Owner location
Woodcliff Lake, NJ, US
Examiner
PARKS, KIMBERLY L
Holders and representatives
Holders
Eagle Pharmaceuticals, Inc.
Representatives
John Mueller BakerHostetler
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Commercialization of pharmaceutical productsmarketing in the field of pharmaceutical products
Class 42
Pharmaceutical product development for others
Publications
History of USPTO decisions and trademark events.
42 publications found
NP89
NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED
03/17/2026
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/17/2026
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
03/17/2026
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
03/17/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/17/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
12/29/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/29/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/09/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/09/2022
E815
TEAS SECTION 8 & 15 RECEIVED
12/20/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/29/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2015
PUBO
PUBLISHED FOR OPPOSITION
10/13/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/15/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/04/2015
GNFR
FINAL REFUSAL E-MAILED
04/04/2015
CNFR
FINAL REFUSAL WRITTEN
04/04/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/06/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/06/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/05/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2014
GNRT
NON-FINAL ACTION E-MAILED
09/16/2014
CNRT
NON-FINAL ACTION WRITTEN
09/16/2014
DOCK
ASSIGNED TO EXAMINER
09/11/2014
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/26/2014
ALIE
ASSIGNED TO LIE
08/19/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/14/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2014
NWAP
NEW APPLICATION ENTERED
06/03/2014
Continuous trademark protection
Get notified about every new filing that threatens EAGLE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.